SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 20.39 |
Enterprise Value ($M) | 6.97 |
Book Value ($M) | 34.70 |
Book Value / Share | 1.25 |
Price / Book | 0.59 |
NCAV ($M) | 29.68 |
NCAV / Share | 1.07 |
Price / NCAV | 0.69 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.27 |
Return on Assets (ROA) | -0.21 |
Return on Equity (ROE) | -0.25 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.81 |
Current Ratio | 5.81 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 37.95 |
Assets | 42.98 |
Liabilities | 8.28 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Phoenix Holdings Ltd. | 8.87 | -4.07 | |
13G/A | Armistice Capital, Llc | 4.99 | -31.47 | |
13D/A | Arkin Moshe | 60.80 | ||
13G | Migdal Insurance & Financial Holdings Ltd. | 5.31 | -0.25 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
18,830 | 45,390 | 41.48 | |
30,248 | 88,258 | 34.27 | |
32,816 | 63,540 | 51.65 | |
9,255 | 77,433 | 11.95 | |
(click for more detail) |
Similar Companies | |
---|---|
SGMO – Sangamo Therapeutics, Inc. | SHPH – Shuttle Pharmaceuticals Holdings, Inc. |
SILO – Silo Pharma, Inc. | SLRX – Salarius Pharmaceuticals, Inc. |
SLS – SELLAS Life Sciences Group, Inc. |
Financial data and stock pages provided by
Fintel.io